Signs of mold toxicity mirror symptoms of common health nuisances...but a nationally recognized mold remediator says exposure ...
PEMGARDA (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 millionPreliminary Q4 2024 total operating costs and expenses of approximately ...
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions ...
The global Orthopedic Imaging Equipment Market was valued at USD 11,023.7 million in 2024 and is expected to reach USD 17,079 ...